-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NTM-006 in Osteoarthritis Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTM-006 in Osteoarthritis Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NTM-006 in Osteoarthritis Pain Drug Details: JNJ-10450232 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pravibismane in Wounds
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pravibismane in Wounds report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pravibismane in Wounds Drug Details: Pravibismane (MBN-101) is under development for the treatment...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Pravibismane in Diabetic Foot Infection (DFI)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pravibismane in Diabetic Foot Infection (DFI) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pravibismane in Diabetic Foot Infection (DFI) Drug Details: Pravibismane (MBN-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Epetraborole in Burkholderia pseudomallei Infections (Melioidosis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Epetraborole in Burkholderia pseudomallei Infections (Melioidosis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epetraborole in Burkholderia pseudomallei Infections (Melioidosis) Drug Details: Epetraborole is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ketorolac Tromethamine in Post-Operative Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Ketorolac Tromethamine in Post-Operative Pain Drug Details:Ketorolac tromethamine (NTM-001) is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Molgramostim in Lung Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Molgramostim in Lung Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Molgramostim in Lung Disease Drug Details: Molgramostim (Molgradex) is under development for...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Company Profile
RedHill Biopharma Ltd – Company Profile
RedHill Biopharma Ltd (RedHill) is a specialty biopharmaceutical company that develops and commercializes therapeutics for gastrointestinal (GI) diseases and cancer. The company’s commercial product portfolio consists of branded prescription drugs including a combination of omeprazole, amoxicillin and rifabutin omeprazole; naloxegol; and rifamycin. RedHill is investigating its pipeline candidates for the treatment of Crohn's disease, non-tuberculous mycobacterial infection (NTM) infections, gastroenteritis, gastritis, irritable bowel syndrome with diarrhea (IBS-D), bowel cleanser, cancer and novel coronavirus disease (COVID-19). The company has a subsidiary...
Add to Basket -
Company Profile
Insmed Inc – Company Profile
Insmed Inc (Insmed) is a biopharmaceutical company that focuses on developing novel therapeutics for rare diseases. Its marketed product, Arikayce (liposomal amikacin for inhalation) is indicated for mycobacterium avium complex (MAC) lung infection and NTM lung infections caused by MAC in adult patients. The company uses its proprietary, liposomal technology to develop its novel drug candidates. Its pipeline products include brensocatib for non-cystic fibrosis (non-CF) bronchiectasis, cystic fibrosis and COVID-19; TPIP, an inhaled formulation of a treprostinil prodrug for pulmonary...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NTM-006
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry NTM-006 Drug Details JNJ-10450232 is under development for the treatment of postoperative dental pain...